News | March 18, 2008

Hazardous Drug Handling Course Offered by Baxa for Nurses, Doctors

March 19, 2008 - Baxa Corp. said the latest addition to its STAR (Skills Training, Academics and Resources) Center course offerings is "Safe Handling and Preparation of Hazardous Drugs," developed so nurses, pharmacists and physicians can prepare, handle or administer hazardous drugs.

The course will be held at Baxa's STAR Center in Englewood, CO April 24-25, with subsequent course dates June 19-20 and Aug. 21-22.

The 10-hour course combines hands-on experience with regulatory compliance and industry best practice to provide complete training in hazardous drug compounding and safe handling. The course is designed for front-line pharmacists, technicians, nurses, physicians, pharmacy managers and nursing managers, covering concepts that affect hazardous drug policies and procedures, from engineering controls to the proper use of closed-system drug transfer devices. Course material focuses on proper aseptic techniques and the principles and requirements of hazardous drug (HD) waste and disposal.

Baxa developed the core curriculum with subject matter experts in HD, environmental consulting and USP 797 to prepare professionals for the chapter guideline changes announced in December 2007.

For more information: www.baxa.com/starcenter/

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init